The authors further demonstrated a reverse correlation between PKD1 and MTA1 expression in a transgenic adenocarcinoma of the mouse prostate (TRAMP) model and in samples of human prostate cancer, in which PKD1 expression decreased, whereas MTA1 expression increased with progressed tumor stage [78]. The gene discussed is PKD1; the disease is prostate cancer.